Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 85 to 90 of 90 entries
Sorted by: Best Match Show Resources per page
Eye Movement Desensitization and Reprocessing vs. Treatment-as-Usual for Non-Specific Chronic Back Pain Patients with Psychological Trauma: A Randomized Controlled Pilot Study.

Frontiers in psychiatry

Gerhardt A, Leisner S, Hartmann M, Janke S, Seidler GH, Eich W, Tesarz J.
PMID: 28066274
Front Psychiatry. 2016 Dec 20;7:201. doi: 10.3389/fpsyt.2016.00201. eCollection 2016.

OBJECTIVE: Eye movement desensitization and reprocessing (EMDR)-an evidence-based approach to eliminate emotional distress from traumatic experiences-was recently suggested for the treatment of chronic pain. The aim of this study was to estimate preliminary efficacy of a pain-focused EMDR intervention...

Cite
Gerhardt A, Leisner S, Hartmann M, et al. Eye Movement Desensitization and Reprocessing vs. Treatment-as-Usual for Non-Specific Chronic Back Pain Patients with Psychological Trauma: A Randomized Controlled Pilot Study. Front Psychiatry. 2016;7:201doi: 10.3389/fpsyt.2016.00201.
Gerhardt, A., Leisner, S., Hartmann, M., Janke, S., Seidler, G. H., Eich, W., & Tesarz, J. (2016). Eye Movement Desensitization and Reprocessing vs. Treatment-as-Usual for Non-Specific Chronic Back Pain Patients with Psychological Trauma: A Randomized Controlled Pilot Study. Frontiers in psychiatry, 7201. https://doi.org/10.3389/fpsyt.2016.00201
Gerhardt, Andreas, et al. "Eye Movement Desensitization and Reprocessing vs. Treatment-as-Usual for Non-Specific Chronic Back Pain Patients with Psychological Trauma: A Randomized Controlled Pilot Study." Frontiers in psychiatry vol. 7 (2016): 201. doi: https://doi.org/10.3389/fpsyt.2016.00201
Gerhardt A, Leisner S, Hartmann M, Janke S, Seidler GH, Eich W, Tesarz J. Eye Movement Desensitization and Reprocessing vs. Treatment-as-Usual for Non-Specific Chronic Back Pain Patients with Psychological Trauma: A Randomized Controlled Pilot Study. Front Psychiatry. 2016 Dec 20;7:201. doi: 10.3389/fpsyt.2016.00201. eCollection 2016. PMID: 28066274; PMCID: PMC5167699.
Copy Download .nbib Format: NLM
Knowledge and practice concerning swallowing disorders in hemiplegic patients among nurses of Bobo-Dioulasso urban primary health care centers in Burkina Faso.

eNeurologicalSci

Diendéré J, Sawadogo A, Millogo A, Ilboudo A, Napon C, Méda N, Kaboré J, Méda ZC, Testa J, Preux PM, Salle JY, Desport JC.
PMID: 29430536
eNeurologicalSci. 2016 Feb 24;3:48-53. doi: 10.1016/j.ensci.2016.02.008. eCollection 2016 Jun.

INTRODUCTION: The quality of management of swallowing disorders (SD) from admission onwards influences the patients' nutritional status and their prognosis. Neurological diseases are the main causes of SD, affecting one in three patients with hemiplegia (Hp). In Burkina Faso...

Cite
Diendéré J, Sawadogo A, Millogo A, et al. Knowledge and practice concerning swallowing disorders in hemiplegic patients among nurses of Bobo-Dioulasso urban primary health care centers in Burkina Faso. eNeurologicalSci. 2016;3:48-53doi: 10.1016/j.ensci.2016.02.008.
Diendéré, J., Sawadogo, A., Millogo, A., Ilboudo, A., Napon, C., Méda, N., Kaboré, J., Méda, Z. C., Testa, J., Preux, P. M., Salle, J. Y., & Desport, J. C. (2016). Knowledge and practice concerning swallowing disorders in hemiplegic patients among nurses of Bobo-Dioulasso urban primary health care centers in Burkina Faso. eNeurologicalSci, 348-53. https://doi.org/10.1016/j.ensci.2016.02.008
Diendéré, Jeoffray, et al. "Knowledge and practice concerning swallowing disorders in hemiplegic patients among nurses of Bobo-Dioulasso urban primary health care centers in Burkina Faso." eNeurologicalSci vol. 3 (2016): 48-53. doi: https://doi.org/10.1016/j.ensci.2016.02.008
Diendéré J, Sawadogo A, Millogo A, Ilboudo A, Napon C, Méda N, Kaboré J, Méda ZC, Testa J, Preux PM, Salle JY, Desport JC. Knowledge and practice concerning swallowing disorders in hemiplegic patients among nurses of Bobo-Dioulasso urban primary health care centers in Burkina Faso. eNeurologicalSci. 2016 Feb 24;3:48-53. doi: 10.1016/j.ensci.2016.02.008. eCollection 2016 Jun. PMID: 29430536; PMCID: PMC5803065.
Copy Download .nbib Format: NLM
Neuregulin 4 Downregulation Induces Insulin Resistance in 3T3-L1 Adipocytes through Inflammation and Autophagic Degradation of GLUT4 Vesicles.

International journal of molecular sciences

Díaz-Sáez F, Blanco-Sinfreu C, Archilla-Ortega A, Sebastian D, Romero M, Hernández-Alvarez MI, Mora S, Testar X, Ricart W, Fernández-Real JM, Moreno-Navarrete JM, Aragonés J, Camps M, Zorzano A, Gumà A.
PMID: 34884763
Int J Mol Sci. 2021 Nov 30;22(23). doi: 10.3390/ijms222312960.

The adipokine Neuregulin 4 (Nrg4) protects against obesity-induced insulin resistance. Here, we analyze how the downregulation of Nrg4 influences insulin action and the underlying mechanisms in adipocytes. Validated shRNA lentiviral vectors were used to generate scramble (Scr) and Nrg4...

Cite
Díaz-Sáez F, Blanco-Sinfreu C, Archilla-Ortega A, et al. Neuregulin 4 Downregulation Induces Insulin Resistance in 3T3-L1 Adipocytes through Inflammation and Autophagic Degradation of GLUT4 Vesicles. Int J Mol Sci. 2021;22(23)doi: 10.3390/ijms222312960.
Díaz-Sáez, F., Blanco-Sinfreu, C., Archilla-Ortega, A., Sebastian, D., Romero, M., Hernández-Alvarez, M. I., Mora, S., Testar, X., Ricart, W., Fernández-Real, J. M., Moreno-Navarrete, J. M., Aragonés, J., Camps, M., Zorzano, A., & Gumà, A. (2021). Neuregulin 4 Downregulation Induces Insulin Resistance in 3T3-L1 Adipocytes through Inflammation and Autophagic Degradation of GLUT4 Vesicles. International journal of molecular sciences, 22(23), . https://doi.org/10.3390/ijms222312960
Díaz-Sáez, Francisco, et al. "Neuregulin 4 Downregulation Induces Insulin Resistance in 3T3-L1 Adipocytes through Inflammation and Autophagic Degradation of GLUT4 Vesicles." International journal of molecular sciences vol. 22,23 (2021). doi: https://doi.org/10.3390/ijms222312960
Díaz-Sáez F, Blanco-Sinfreu C, Archilla-Ortega A, Sebastian D, Romero M, Hernández-Alvarez MI, Mora S, Testar X, Ricart W, Fernández-Real JM, Moreno-Navarrete JM, Aragonés J, Camps M, Zorzano A, Gumà A. Neuregulin 4 Downregulation Induces Insulin Resistance in 3T3-L1 Adipocytes through Inflammation and Autophagic Degradation of GLUT4 Vesicles. Int J Mol Sci. 2021 Nov 30;22(23). doi: 10.3390/ijms222312960. PMID: 34884763.
Copy Download .nbib Format: NLM
Omalizumab in cold urticaria in children: Retrospective case series of 13 patients, review of the literature.

Annales de dermatologie et de venereologie

Briand C, Tetart F, Soria A, Staumont-Sallé D, Sterling B, Boralevi F, Castelain Lakkis F, Du-Thanh A, Raison-Peyron N, Chiaverini C.
PMID: 34503855
Ann Dermatol Venereol. 2021 Dec;148(4):269-271. doi: 10.1016/j.annder.2021.08.002. Epub 2021 Sep 06.

No abstract available.

Cite
Briand C, Tetart F, Soria A, et al. Omalizumab in cold urticaria in children: Retrospective case series of 13 patients, review of the literature. Ann Dermatol Venereol. 2021;148(4):269-271doi: 10.1016/j.annder.2021.08.002.
Briand, C., Tetart, F., Soria, A., Staumont-Sallé, D., Sterling, B., Boralevi, F., Castelain Lakkis, F., Du-Thanh, A., Raison-Peyron, N., & Chiaverini, C. (2021). Omalizumab in cold urticaria in children: Retrospective case series of 13 patients, review of the literature. Annales de dermatologie et de venereologie, 148(4), 269-271. https://doi.org/10.1016/j.annder.2021.08.002
Briand, C, et al. "Omalizumab in cold urticaria in children: Retrospective case series of 13 patients, review of the literature." Annales de dermatologie et de venereologie vol. 148,4 (2021): 269-271. doi: https://doi.org/10.1016/j.annder.2021.08.002
Briand C, Tetart F, Soria A, Staumont-Sallé D, Sterling B, Boralevi F, Castelain Lakkis F, Du-Thanh A, Raison-Peyron N, Chiaverini C. Omalizumab in cold urticaria in children: Retrospective case series of 13 patients, review of the literature. Ann Dermatol Venereol. 2021 Dec;148(4):269-271. doi: 10.1016/j.annder.2021.08.002. Epub 2021 Sep 06. PMID: 34503855.
Copy Download .nbib Format: NLM
The alternative serotonin transporter promoter P2 impacts gene function in females with irritable bowel syndrome.

Journal of cellular and molecular medicine

Mohr S, Fritz N, Hammer C, Martínez C, Berens S, Schmitteckert S, Wahl V, Schmidt M, Houghton LA, Goebel-Stengel M, Kabisch M, Götze D, Milovač I, D'Amato M, Zheng T, Röth R, Mönnikes H, Engel F, Gauss A, Tesarz J, Raithel M, Andresen V, Frieling T, Keller J, Pehl C, Stein-Thöringer C, Clarke G, Kennedy PJ, Cryan JF, Dinan TG, Quigley EMM, Spiller R, Beltrán C, Madrid AM, Torres V, Pérez de Arce E, Herzog W, Mayer EA, Sayuk G, Gazouli M, Karamanolis G, Kapur-Pojskič L, Bustamante M, Rabionet R, Estivil X, Franke A, Lieb W, Boeckxstaens G, Wouters MM, Simrén M, Rappold GA, Vicario M, Santos J, Schaefert R, Lorenzo-Bermejo J, Niesler B.
PMID: 34165249
J Cell Mol Med. 2021 Aug;25(16):8047-8061. doi: 10.1111/jcmm.16736. Epub 2021 Jun 24.

Irritable bowel syndrome (IBS) is a gut-brain disorder in which symptoms are shaped by serotonin acting centrally and peripherally. The serotonin transporter gene SLC6A4 has been implicated in IBS pathophysiology, but the underlying genetic mechanisms remain unclear. We sequenced...

Cite
Mohr S, Fritz N, Hammer C, et al. The alternative serotonin transporter promoter P2 impacts gene function in females with irritable bowel syndrome. J Cell Mol Med. 2021;25(16):8047-8061doi: 10.1111/jcmm.16736.
Mohr, S., Fritz, N., Hammer, C., Martínez, C., Berens, S., Schmitteckert, S., Wahl, V., Schmidt, M., Houghton, L. A., Goebel-Stengel, M., Kabisch, M., Götze, D., Milovač, I., D'Amato, M., Zheng, T., Röth, R., Mönnikes, H., Engel, F., Gauss, A., Tesarz, J., Raithel, M., Andresen, V., Frieling, T., Keller, J., Pehl, C., Stein-Thöringer, C., Clarke, G., Kennedy, P. J., Cryan, J. F., Dinan, T. G., Quigley, E. M. M., Spiller, R., Beltrán, C., Madrid, A. M., Torres, V., Pérez de Arce, E., Herzog, W., Mayer, E. A., Sayuk, G., Gazouli, M., Karamanolis, G., Kapur-Pojskič, L., Bustamante, M., Rabionet, R., Estivil, X., Franke, A., Lieb, W., Boeckxstaens, G., Wouters, M. M., Simrén, M., Rappold, G. A., Vicario, M., Santos, J., Schaefert, R., Lorenzo-Bermejo, J., & Niesler, B. (2021). The alternative serotonin transporter promoter P2 impacts gene function in females with irritable bowel syndrome. Journal of cellular and molecular medicine, 25(16), 8047-8061. https://doi.org/10.1111/jcmm.16736
Mohr, Sandra, et al. "The alternative serotonin transporter promoter P2 impacts gene function in females with irritable bowel syndrome." Journal of cellular and molecular medicine vol. 25,16 (2021): 8047-8061. doi: https://doi.org/10.1111/jcmm.16736
Mohr S, Fritz N, Hammer C, Martínez C, Berens S, Schmitteckert S, Wahl V, Schmidt M, Houghton LA, Goebel-Stengel M, Kabisch M, Götze D, Milovač I, D'Amato M, Zheng T, Röth R, Mönnikes H, Engel F, Gauss A, Tesarz J, Raithel M, Andresen V, Frieling T, Keller J, Pehl C, Stein-Thöringer C, Clarke G, Kennedy PJ, Cryan JF, Dinan TG, Quigley EMM, Spiller R, Beltrán C, Madrid AM, Torres V, Pérez de Arce E, Herzog W, Mayer EA, Sayuk G, Gazouli M, Karamanolis G, Kapur-Pojskič L, Bustamante M, Rabionet R, Estivil X, Franke A, Lieb W, Boeckxstaens G, Wouters MM, Simrén M, Rappold GA, Vicario M, Santos J, Schaefert R, Lorenzo-Bermejo J, Niesler B. The alternative serotonin transporter promoter P2 impacts gene function in females with irritable bowel syndrome. J Cell Mol Med. 2021 Aug;25(16):8047-8061. doi: 10.1111/jcmm.16736. Epub 2021 Jun 24. PMID: 34165249; PMCID: PMC8358858.
Copy Download .nbib Format: NLM
Non-atherosclerotic cause of claudication: cystic adventitial disease of the popliteal artery.

ANZ journal of surgery

Tesar J, Moult V, Quinn S.
PMID: 33969613
ANZ J Surg. 2021 May 10; doi: 10.1111/ans.16920. Epub 2021 May 10.

No abstract available.

Cite
Tesar J, Moult V, Quinn S. Non-atherosclerotic cause of claudication: cystic adventitial disease of the popliteal artery. ANZ J Surg. 2021;doi: 10.1111/ans.16920.
Tesar, J., Moult, V., & Quinn, S. (2021). Non-atherosclerotic cause of claudication: cystic adventitial disease of the popliteal artery. ANZ journal of surgery, . https://doi.org/10.1111/ans.16920
Tesar, Joshua, et al. "Non-atherosclerotic cause of claudication: cystic adventitial disease of the popliteal artery." ANZ journal of surgery vol. (2021). doi: https://doi.org/10.1111/ans.16920
Tesar J, Moult V, Quinn S. Non-atherosclerotic cause of claudication: cystic adventitial disease of the popliteal artery. ANZ J Surg. 2021 May 10; doi: 10.1111/ans.16920. Epub 2021 May 10. PMID: 33969613.
Copy Download .nbib Format: NLM
Showing 85 to 90 of 90 entries